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Up to 15 % of colorectal cancer (CRC) patients present with obstructive or perforated tumours, and 
require emergency surgery. The Hartmann's procedure (HP) provides the opportunity to achieve a 
potentially curative (R0) resection, while minimizing surgical trauma in poor-risk patients. Hartmann’s 
procedure, first described by the French surgeon Henri Albert Hartmann in 1921. 
Aim. To assess the surgical (operative mortality), and oncological (long-term survival after curative 
resection) results of emergency HP for obstructive or perforated left-sided CRC. 
Methods. A retrospective review of 50 patients who underwent emergency HP for 
perforated/obstructive CRC in surgical department  SRCH in period 2007– 2013. 
Results. Median age of patients was 75 (range 22–95) years and the indications for HP were 
obstruction (32) and perforation (18 patients). Operative mortality and morbidity were 8 % and 26 % 
respectively. 35 patients (70 %) were operated with a curative intent; in this group, overall 1-, 3- and 5-
year survival rates were 80 %, 54 % and 40 %. In univariate analysis, the presence of lymph node 
metastases was associated with poor 5-year survival (62 % [Stage II] vs. 27 % [Stage III], log-rank test, p 
= 0.02). Eleven patients (22 %) had their operation reversed with a median delay of 225 (range 94–390) 
days. In this subgroup, two patients died from distant metastases, but there were no instances of loco-
regional recurrence. 
Conclusion. Hartmann's operation remains a good option to palliate symptoms in 30 % of patients 
with left-sided CRC who are not candidates to a curative resection. For those who have a curative 
resection, the oncological outcome is acceptable, especially stage II patients, who appear to benefit the 
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